<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rsp</journal-id><journal-title-group><journal-title xml:lang="ru">Научно-практическая ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Rheumatology Science and Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-4484</issn><issn pub-type="epub">1995-4492</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/1995-4484-2017-572-575</article-id><article-id custom-type="elpub" pub-id-type="custom">rsp-2442</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НОВОСТИ РЕВМАТОЛОГИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>RHEUMATOLOGY NEWS</subject></subj-group></article-categories><title-group><article-title>Новая редакция Т2Т (лечение до достижения цели) при спондилоартритах</article-title><trans-title-group xml:lang="en"><trans-title>THE NEW VERSION OF T2T (TREAT-TO-TARGET) FOR SPONDYLOARTHRITIDES</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Эрдес</surname><given-names>Ш. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Erdes</surname><given-names>Sh. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522 Москва, Каширское шоссе, 34А</p></bio><bio xml:lang="en"><p>34A, Kashirskoe Shosse, Moscow 115522</p></bio><email xlink:type="simple">123456_57@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»<country>Россия</country></aff><aff xml:lang="en">V.A. Nasonova Research Institute of Rheumatology<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>27</day><month>10</month><year>2017</year></pub-date><volume>55</volume><issue>5</issue><fpage>572</fpage><lpage>575</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Эрдес Ш.Ф., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Эрдес Ш.Ф.</copyright-holder><copyright-holder xml:lang="en">Erdes S.F.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://rsp.mediar-press.net/rsp/article/view/2442">https://rsp.mediar-press.net/rsp/article/view/2442</self-uri><abstract><p>В сообщении коротко представлена обновленная версия рекомендаций по лечению до достижения цели (Treat to Target – Т2Т) для спондилоартритов.</p></abstract><trans-abstract xml:lang="en"><p>The communication briefly presents the updated version of treat-to- target (T2T) recommendations for spondyloarthritides.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>спондилоартриты</kwd><kwd>лечение до достижения цели</kwd><kwd>Т2Т</kwd><kwd>рекомендации</kwd></kwd-group><kwd-group xml:lang="en"><kwd>spondyloarthritides</kwd><kwd>treat-to-target (T2T)</kwd><kwd>recommendations</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Smolen JS, Braun J, Dougados M, et al. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis. 2014;73(1):6-16. doi: 10.1136/annrheumdis-2013-203419</mixed-citation><mixed-citation xml:lang="en">Smolen JS, Braun J, Dougados M, et al. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis. 2014;73(1):6-16. doi: 10.1136/annrheumdis-2013-203419</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Эрдес ШФ. Стратегия «Лечение до достижения цели». Научно-практическая ревматология. 2014;52(3):251-3 [Erdes ShF. «Treat-to-target» (T2T) strategy in spondyloarthritis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2014:52(3):251-3 (In Russ.)]. doi: 10.14412/1995-4484-2014-251-253</mixed-citation><mixed-citation xml:lang="en">Эрдес ШФ. Стратегия «Лечение до достижения цели». Научно-практическая ревматология. 2014;52(3):251-3 [Erdes ShF. «Treat-to-target» (T2T) strategy in spondyloarthritis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2014:52(3):251-3 (In Russ.)]. doi: 10.14412/1995-4484-2014-251-253</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Smolen JS, Schö ls M, Braun J, et al. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Ann Rheum Dis. Published Online First: 06 July 2017. doi: 10.1136/annrheumdis-2017-211734</mixed-citation><mixed-citation xml:lang="en">Smolen JS, Schö ls M, Braun J, et al. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Ann Rheum Dis. Published Online First: 06 July 2017. doi: 10.1136/annrheumdis-2017-211734</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
